Literature DB >> 29183852

Identification of an area predominantly endemic for childhood and adolescent visceral leishmaniasis in central Sudan.

Abdelhafeiz Mahamoud1, Hussam Ali Osman2, Elfadil Mustafa Abass3, Atif El Agib4, Rubens Riscala Madi5, Saul J Semiao-Santos6, Abdallah El Harith7.   

Abstract

Although widely spread throughout Sudan, visceral leishmaniasis (VL) is predominantly endemic in the Gedaref, southern Blue-Nile, and Umrimta areas located in the eastern, southern, and central regions, respectively. Regardless of form (endemic or epidemic), VL occurrence follows similar patterns as all ages and both sexes are affected. From January 2005 to May 2016, we received a total of 563 patients with high suspicion for VL from various endemic areas; 159 were children and adolescents (0.5-18 years) from Umrimta (central Sudan). A significant observation during this 11-year period of uninterrupted monitoring using a standard liquid direct agglutination test (LQ-DAT) version was the exclusive VL occurrence (100%) in the child and adolescent populations of Umrimta when compared with other endemic areas (27.3%-48.0%). Among 12 child and adolescent suspects who initially tested marginal in the standard LQ-DAT, 6 scored unequivocally positive readings both in an improved LQ-DAT version (based on an autochthonous Leishmania donovani strain) and rK28 VL reference test. None of the 4 (2.5%) VL adult suspects (≥19years) referred had positive outcomes in the improved LQ-DAT version or the VL reference freeze-dried direct agglutination and rK28 tests. Further incorporation of antigens derived from autochthonous L. donovani strains from Umrimta (central Sudan) or Gedaref (eastern Sudan) in LQ-DAT significantly increased the agglutination titer levels in the respective VL homologous sera (p=0.0263 T=505 and p=0.2814T=219), suggesting possible antigenic variation within the predominant Sudanese L. donovani complex. Additional research is required to determine characteristics other than the serologically-based ones reported for the L. donovani strain involved.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolecence; Antigenic variation; Central Sudan; Childhood; Demography; L. donovani

Mesh:

Year:  2017        PMID: 29183852     DOI: 10.1016/j.actatropica.2017.11.010

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Modifications in a Reference Freeze-Dried Direct Agglutination Test to Improve Visceral Leishmaniasis Detection.

Authors:  Abdallah El Harith; Yousif Awad; Abdelhafeiz Mahamoud; Elfadil Abass; Durria Mansour; Claudia Moura de Melo; Rubens Riscala Madi; Saul J Semiao-Santos; Hussam Ali Osman
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

Review 2.  Leishmaniasis in Saudi Arabia: Current situation and future perspectives.

Authors:  Elfadil Abass; Zainab Al-Hashem; Lamya Zohair Yamani
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

3.  Patterns, Outcomes and Predictors of Pediatric Medical Admissions at Gadarif Hospital in Eastern Sudan.

Authors:  Mohammed Ahmed A Ahmed; Imad R Musa; Hyder M Mahgoub; Abdullah Al-Nafeesah; Osama Al-Wutayd; Ishag Adam
Journal:  Front Pediatr       Date:  2022-01-27       Impact factor: 3.418

4.  Diagnosis and Causative Species of Visceral Leishmaniasis in Southwest Saudi Arabia.

Authors:  Aymen Abdelhaleem; Nabil Dhayhi; Mohamed Salih Mahfouz; Ommer Dafalla; Mansour Mubarki; Fahad Hamedhi; Abdullah Al Hazmi; Haider Al Arishi
Journal:  Am J Trop Med Hyg       Date:  2021-07-06       Impact factor: 3.707

Review 5.  Are We Now Well Prepared for Another Major Visceral Leishmaniasis Epidemic in Sudan?

Authors:  Abdallah El Harith; Abdelhafeiz Mahamoud; Yousif Awad; Durria Mansour; Elfadil Mustafa Abass; Atif El Agib; Rubens Riscala Madi; Saul J Semiao-Santos; Hussam Ali Osman
Journal:  Open Forum Infect Dis       Date:  2019-05-15       Impact factor: 3.835

Review 6.  In transition: current health challenges and priorities in Sudan.

Authors:  Esmita Charani; Aubrey J Cunnington; AlaEldin H A Yousif; Mohammed Seed Ahmed; Ammar E M Ahmed; Souad Babiker; Shahinaz Badri; Wouter Buytaert; Michael A Crawford; Mustafa I Elbashir; Kamal Elhag; Kamal E Elsiddig; Nadey Hakim; Mark R Johnson; Alexander D Miras; Mohamed O Swar; Michael R Templeton; Simon David Taylor-Robinson
Journal:  BMJ Glob Health       Date:  2019-08-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.